Moderna Surges 14% as Melanoma Vaccine Data Makes It the S&P 500's Biggest Mover
Moderna closed up 14.36% Tuesday, the S&P 500's top gainer, as melanoma vaccine data kept rippling through the market.
Delta Bets on AI to Cut Costs and Lift Profit Margins by 50%
Delta CEO Ed Bastian says AI could push operating margins from 10% to 15%, even as lawmakers scrutinize the airline's pricing tools.
The Reason Imax Hits an All-Time High
IMAX shares broke $50 for the first time ever this week, riding a record-shattering month powered almost entirely by Nolan's 'The Odyssey.'
SpaceX's Stock Isn't Failing. It's Pricing What Vertical Integration Actually Costs.
SpaceX's post-IPO slide isn't hype fading. It's the market finally seeing what the AI empire costs Starlink.
The IBM Crash Is a Memory Chip Story, Not an AI Story
IBM's worst day in decades looks like an AI-spending scare. It's actually the memory shortage rewriting enterprise budgets.
The Data Center Lease Is Wall Street's New Subprime Instrument
AI data center debt is pooled and tranched like 2008 mortgage bonds. The assets are real — but the risk-transfer machinery looks familiar.
The SpaceX IPO's Real Story Isn't Musk's Net Worth — It's the Balance Sheet Nobody's Pricing In
Musk's IPO windfall is the headline. The real risk is buried in the prospectus: 27% of the raise already owed.
The Biggest IPO in History Wanted to Be Different. Wall Street Wouldn't Let It.
SpaceX promised retail investors a seat at the table. Wall Street sat down first.
The 401(k) Default Trap
The default trap isn't a personal failure. It's a design flaw — and it's quietly costing millions of workers their retirement.